Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET

Mol Psychiatry. 2015 Oct;20(10):1141. doi: 10.1038/mp.2015.146.

M Brendel¹, A Jaworska^{2

3}, J Herms^{2

4}, J Trambauer⁵, C Rötzer¹, F-J Gildehaus¹, J Carlsen¹, P Cumming⁶, J Bylund⁷, T Luebbers⁸, P Bartenstein^{1

4}, H Steiner^{2

5}, C Haass^{2

4

5}, K Baumann⁹, A Rominger^{1

4}

¹ Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany.
² DZNE-German Center for Neurodegenerative Diseases, Munich, Germany.
³ Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Warsaw, Poland.
⁴ Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
⁵ Biomedical Center (BMC), Ludwig-Maximilians-University of Munich, Munich, Germany.
⁶ Department of Psychiatry, University of Oslo, Oslo, Norway.
⁷ Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.
⁸ Roche Pharma Research and Early Development, Small Molecule Research, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.
⁹ Roche Pharma Research and Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland.

No abstract available

MeSH terms